Document:

Exhibit
      10.2

    

    

    Schedule
      of Investors

     

    
 

    
      	
              Investor

            	 	
              #
                of

              Shares

            	
               

            	
              Aggregate
                Purchase Price

            	 
	 	 	 	 	 	 
	
              Heartland
                Group, Inc. on behalf of 

              Heartland
                Value Fund

            	 	 	
              400,000

            	 	
              $

            	
              3,400,000.00

            	 
	 	 	 	 	 	 	 	 
	
              The
                Pinnacle Fund, LP

            	 	 	
              352,941

            	 	
              $

            	
              2,999,998.50

            	 
	 	 	 	 	 	 	 	 
	
              MAC
                & CO

              c/o
                Public Sector Pension Investment Board

              Wellington
                Management Company, LLP

            	 	 	
              200,000

            	 	
              $

            	
              1,700,000.00

            	 
	 	 	 	 	 	 	 	 
	
              ELL
                & CO

              c/o
                Radian Group, Inc.

              Wellington
                Management Company, LLP

            	 	 	
              23,000

            	 	
              $

            	
              195,500.00

            	 
	 	 	 	 	 	 	 	 
	
              David
                Cumming

            	 	 	
              16,500

            	 	
              $

            	
              140,250.00AGREEMENT AND PLAN OF SHARE EXCHANGE

                                  by and among

                                AuraSound, Inc.,
                            a California corporation

                                       and

                               the Shareholders of
                                AuraSound, Inc.,

                                on the one hand;

                                       and

                                 Hemcure, Inc.,
                             an Nevada corporation,

                          SBC Business Consulting, LLC,
                      a Delaware limited liability company,

                                       and

                               Bartly J. Loethen,
                                 an individual,

                                on the other hand

                                February 16, 2007

<PAGE>

                      AGREEMENT AND PLAN OF SHARE EXCHANGE

      This Agreement and Plan of Share  Exchange,  dated as of February 16, 2007
(this  "Agreement"),  is made and entered into by and among  AuraSound,  Inc., a
California corporation ("Aura Sound"), and the shareholders of Aura Sound listed
on Schedule I attached hereto (each, an "Aura Sound Shareholder",  collectively,
the "Aura Sound Shareholders"),  on the one hand; and Hemcure,  Inc., a publicly
traded  Nevada  corporation   (OTCBB:   HMCU)   ("Hemcure"),   Synergy  Business
Consulting,   LLC,  a  Delaware  limited  liability  company  and  the  majority
shareholder of Hemcure  ("SBC"),  and Bartly J. Loethen,  the managing member of
SBC ("Loethen"), on the other hand.

                                    RECITALS

      WHEREAS, the respective boards of directors of Hemcure and Aura Sound have
adopted resolutions  approving and adopting the share exchange described in this
Agreement (the "Exchange") upon the terms and conditions set forth herein;

      WHEREAS,  the Exchange  ratio is 1 share of Hemcure  common stock for each
share of Aura Sound common stock;

      WHEREAS, after giving effect to the Share Cancellation Agreement, dated on
or about  January 4, 2007,  by and among Aura Sound,  Arthur Liu and each of the
Aura Sound shareholders signatory thereto (the "Share Cancellation  Agreement"),
and the Note  Conversion  Agreement and Release,  dated on or about February 16,
2007,  by and among Aura Sound and the lenders of Aura Sound  signatory  thereto
(the "Note Conversion  Agreement)",  each Aura Sound Shareholder owns the number
of shares of common  stock of Aura  Sound  set forth  opposite  such Aura  Sound
Shareholder's name in Column I on Schedule I attached hereto (collectively,  the
"Aura Sound Shares");

      WHEREAS,  the Aura  Sound  Shareholders  own,  collectively,  an amount of
shares of common stock of Aura Sound constituting at least 90% of the issued and
outstanding  capital stock of Aura Sound, and the Aura Sound Shareholders desire
to exchange their  respective  portions of the Aura Sound Shares pursuant to the
terms and conditions of this Agreement;

      WHEREAS, SBC and Loethen will enter into this Agreement for the purpose of
making certain  representations,  warranties,  covenants,  indemnifications  and
agreements;

      WHEREAS,  Aura Sound will enter  into this  Agreement  for the  purpose of
evidencing its consent to the  consummation  of the Exchange and for the purpose
of making certain representations, warranties, covenants and agreements;

      WHEREAS,  it is intended that the terms and  conditions of this  Agreement
comply in all respects with Section  368(a)(1)(B)  of the Internal  Revenue Code
(the "Code") and the  regulations  corresponding  thereto,  so that the Exchange
shall qualify as a tax free reorganization under the Code;

      NOW, THEREFORE,  the parties hereto,  intending to be legally bound, agree
as follows:

                                    ARTICLE 1
                                  THE EXCHANGE

      1.1  Exchange  of Shares.  Upon the terms and  subject  to the  conditions
hereof, at the Closing the Aura Sound  Shareholders will sell,  convey,  assign,
transfer and deliver to Hemcure stock  certificates  representing the Aura Sound
Shares, and Hemcure will issue to each Aura Sound  Shareholder,  in exchange for
such Aura Sound  Shareholder's pro rata portion of the Aura Sound Shares, one or
more stock  certificates  representing  the  number of shares of Hemcure  common
stock set forth  opposite  such Aura  Sound  Shareholder's  name in Column II on
Schedule I attached hereto (collectively,  the "Hemcure Shares").  The aggregate
number of Hemcure  Shares to be issued to the Aura Sound  Shareholders  will not
exceed 11,505,305 shares of common stock.

<PAGE>

      1.2 Closing.  The closing of the Exchange (the "Closing") shall take place
on the date when all of the  closing  conditions  set forth in Article 7 of this
Agreement  are  either  satisfied  or  waived,  or on such  other date as may be
mutually  agreed  upon by the  parties.  Such date is  referred to herein as the
"Closing Date".

      1.3 Articles of Exchange. Immediately following the Closing, Hemcure shall
file Articles of Exchange with the Secretary of State of Nevada,  in the form of
Exhibit A hereto.  The transactions  contemplated by this Agreement shall become
effective  at such time as the  Articles of Exchange are duly filed in the State
of Nevada pursuant to Section 92A.240 of the Nevada Revised Statutes.

                                    ARTICLE 2
                  REPRESENTATIONS AND WARRANTIES OF AURA SOUND

      Aura Sound hereby represents and warrants to Hemcure as follows:

      2.1  Organization.  Aura  Sound has been  duly  incorporated,  is  validly
existing  as a  corporation  and is in  good  standing  under  the  laws  of its
jurisdiction  of  incorporation,  and has the  requisite  power  to carry on its
business as now conducted.

      2.2 Capitalization. The authorized capital stock of Aura Sound consists of
100,000,000  shares of common stock,  no par value, of which  11,505,305  shares
will be issued and  outstanding  at the Closing after giving effect to the Share
Cancellation Agreement and the Note Conversion Agreement.  All of the issued and
outstanding  shares of capital stock of Aura Sound are duly authorized,  validly
issued,  fully paid,  non-assessable and free of preemptive rights. There are no
voting  trusts or any other  agreements  or  understandings  with respect to the
voting of Aura Sound's capital stock.

      2.3 Certain Corporate Matters. Aura Sound is duly qualified to do business
as a  corporation  and is in good  standing  in each  jurisdiction  in which the
ownership of its  properties,  the employment of its personnel or the conduct of
its business  requires it to be so qualified,  except where the failure to be so
qualified  would not have a material  adverse  effect on Aura Sound's  financial
condition,  results of  operations  or business.  Aura Sound has full  corporate
power and authority and all  authorizations,  licenses and permits  necessary to
carry on the  business in which it is engaged and to own and use the  properties
owned and used by it.

      2.4  Authority  Relative to this  Agreement.  Aura Sound has the requisite
power  and  authority  to  enter  into  this  Agreement  and to  carry  out  its
obligations hereunder. The execution, delivery and performance of this Agreement
by  Aura  Sound  and  the   consummation  by  Aura  Sound  of  the  transactions
contemplated  hereby have been duly authorized by the board of directors of Aura
Sound and no other  actions on the part of Aura Sound are necessary to authorize
this Agreement or the transactions  contemplated hereby. This Agreement has been
duly and validly  executed and  delivered by Aura Sound and  constitutes a valid
and  binding  agreement  of  Aura  Sound,  enforceable  against  Aura  Sound  in
accordance  with  its  terms,  except  as such  enforcement  may be  limited  by
bankruptcy,  insolvency  or other  similar laws  affecting  the  enforcement  of
creditors' rights generally or by general principles of equity.

                                       3
<PAGE>

      2.5  Consents  and  Approvals;   No  Violations.   Except  for  applicable
requirements of federal  securities laws and state  securities or blue-sky laws,
no filing with, and no permit, authorization,  consent or approval of, any third
party,  public body or authority is necessary for the consummation by Aura Sound
of the  transactions  contemplated by this Agreement.  Neither the execution and
delivery of this Agreement by Aura Sound nor the  consummation  by Aura Sound of
the transactions  contemplated  hereby, nor compliance by Aura Sound with any of
the  provisions  hereof,  will (a) conflict  with or result in any breach of any
provisions of the charter or bylaws of Aura Sound,  (b) result in a violation or
breach of, or constitute (with or without due notice or lapse of time or both) a
default (or give rise to any right of termination, cancellation or acceleration)
under, any of the terms,  conditions or provisions of any note, bond,  mortgage,
indenture,  license,  contract,  agreement or other  instrument or obligation to
which  Aura Sound is a party or by which it or any of its  properties  or assets
may be bound or (c) violate any order, writ, injunction,  decree,  statute, rule
or  regulation  applicable  to Aura Sound,  or any of its  properties or assets,
except in the case of clauses (b) and (c) for  violations,  breaches or defaults
which are not individually or in the aggregate material to Aura Sound.

      2.6 Financial Statements.

            (a) Aura  Sound  has  provided  Hemcure  with a copy of the  audited
balance  sheet of Aura  Sound as at March  31,  2004 and 2005,  and the  related
statement of operations,  stockholders' equity and cash flows for the two fiscal
years then ended,  together with the  unqualified  report  thereon  (except with
respect to  continuation  as a going  concern) of Kabani & Co., LLP  ("Kabani"),
independent auditors (collectively, "Aura Sound's Audited Financials").

            (b) Included in Aura Sound's  Audited  Financials  are the unaudited
balance sheet of Aura Sound as at December 31, 2006,  and the related  statement
of  operations,  stockholders'  equity and cash flows for the nine  months  then
ended, as reviewed by Kabani ("Aura Sound's Interim Financials").

            (c)  Aura  Sound's  Audited  Financials  and  Aura  Sound's  Interim
Financials  (collectively  "Aura  Sound's  Financial  Statements")  (i)  are  in
accordance  with the books and  records  of Aura  Sound,  (ii) are  correct  and
complete in all material  respects,  (iii) fairly present the financial position
and results of operations of Aura Sound as of the dates indicated,  and (iv) are
prepared in  accordance  with U.S.  GAAP  (except that (x)  unaudited  financial
statements  may  not be in  accordance  with  GAAP  because  of the  absence  of
footnotes normally contained therein, and (y) interim (unaudited) financials are
subject to normal year-end audit adjustments that in the aggregate will not have
a material  adverse effect on Aura Sound, its business,  financial  condition or
results of operations.

            (d) AuraSound's Financial Statements constitute all of the financial
statements of AuraSound  required to be included in the Form 8-K due to be filed
with the SEC by Hemcure within four business days of the Closing Date.

      2.7 Tax Matters.

            (a) Aura Sound has duly filed all federal,  state, local and foreign
tax  returns  required  to be filed by or with  respect to it with the  Internal
Revenue Service or other  applicable  taxing  authority,  and no extensions with
respect to such tax returns have been requested or granted.

            (b) Aura  Sound has paid,  or  adequately  reserved  against in Aura
Sound's Financial  Statements,  all material taxes due, or claimed by any taxing
authority to be due, from or with respect to them.

            (c) To the best knowledge of Aura Sound,  there has been no material
issue  raised or  material  adjustment  proposed  (and none is  pending)  by the
Internal Revenue Service or any other taxing authority in connection with any of
Aura Sound's tax returns.

                                       4
<PAGE>

            (d) No waiver or extension of any statute of  limitations  as to any
material  federal,  state,  local or  foreign  tax  matter  has been given by or
requested from Aura Sound.

            For the  purposes  of  this  Section  2.7,  a tax is due  (and  must
therefore  either  be paid  or  adequately  reserved  against  in  Aura  Sound's
Financial  Statements)  only on the last  date  payment  of such tax can be made
without  interest  or  penalties,  whether  such  payment  is due in  respect of
estimated taxes, withholding taxes, required tax credits or any other tax.

      2.8 Books and  Records.  The books and records of Aura Sound  delivered to
Hemcure prior to the Closing fully and fairly reflect the  transactions to which
Aura Sound is a party or by which its properties are bound.

      2.9 Questionable Payments.  Neither Aura Sound, nor any employee, agent or
representative  of Aura Sound has,  directly  or  indirectly,  made any  bribes,
kickbacks,  illegal payments or illegal  political  contributions  using Company
funds or made any payments from Aura Sound's funds to governmental officials for
improper purposes or made any illegal payments from Aura Sound's funds to obtain
or retain business.

      2. 10  Intellectual  Property.  Aura Sound has no  knowledge  of any claim
that, or inquiry as to whether, any product, activity or operation of Aura Sound
infringes  upon  or  involves,  or has  resulted  in the  infringement  of,  any
trademarks, trade-names, service marks, patents, copyrights or other proprietary
rights of any other person, corporation or other entity; and no such proceedings
have been instituted, are pending or are threatened.

      2.11 Litigation. Aura Sound is not subject to any judgment or order of any
court or quasijudicial or administrative agency of any jurisdiction, domestic or
foreign,   nor  is  there  any  charge,   complaint,   lawsuit  or  governmental
investigation  pending against Aura Sound.  Aura Sound is not a plaintiff in any
action, domestic or foreign,  judicial or administrative.  There are no existing
actions,  suits,  proceedings  against or investigations of Aura Sound, and Aura
Sound knows of no basis for such actions, suits,  proceedings or investigations.
There are no unsatisfied  judgments,  orders,  decrees or stipulations affecting
Aura Sound or to which Aura Sound is a party.

      2.12 Legal  Compliance.  To the best  knowledge  of Aura Sound,  after due
investigation,  no claim has been filed against Aura Sound  alleging a violation
of any  applicable  laws or  regulations  of foreign,  federal,  state and local
governments  and all  agencies  thereof.  Aura Sound  holds all of the  material
permits,  licenses,  certificates or other  authorizations of foreign,  federal,
state or local governmental agencies required for the conduct of its business as
presently  conducted;  provided,  however,  Hemcure expressly  acknowledges that
there are pending  petitions with the U.S. Patent and Trademark Office to revive
seven of Aura Sound's patents, which lapsed due to an inadvertent failure to pay
the required  maintenance  fees, and that those seven patents are not considered
invalid or unenforceable for the pendency of those petitions.

      2.13 Disclosure. The representations and warranties and statements of fact
made by Aura Sound in this Agreement are, as applicable,  accurate,  correct and
complete and do not contain any untrue  statement of a material  fact or omit to
state  any  material  fact  necessary  in  order  to  make  the  statements  and
information contained herein not false or misleading.

                                       5
<PAGE>

                                    ARTICLE 3
                         REPRESENTATIONS AND WARRANTIES
                         OF THE AURA SOUND SHAREHOLDERS

      The Aura Sound  Shareholders  hereby  represent  and warrant to Hemcure as
follows:

      3.1 Ownership of the Aura Sound Shares.  Each Aura Sound Shareholder owns,
beneficially  and of record,  good and marketable title to the Aura Sound Shares
set forth opposite such Aura Sound  Shareholder's name in Column I on Schedule I
attached  hereto,  free and  clear of all  security  interests,  liens,  adverse
claims,  encumbrances,  equities,  proxies, options or stockholders' agreements.
Each Aura Sound  Shareholder  represents that such person has no right or claims
whatsoever to any shares of Aura Sound capital  stock,  other than shares listed
opposite such Aura Sound  Shareholder's  name in Column I on Schedule I and does
not have any  options,  warrants or any other  instruments  entitling  such Aura
Sound  Shareholder  to exercise to purchase or convert into shares of Aura Sound
capital  stock.  At the  Closing,  the Aura Sound  Shareholders  will  convey to
Hemcure good and  marketable  title to the Aura Sound Shares,  free and clear of
any security interests, liens, adverse claims, encumbrances,  equities, proxies,
options, stockholders' agreements or restrictions.

      3.2 Authority Relative to this Agreement. This Agreement has been duly and
validly executed and delivered by each Aura Sound  Shareholder and constitutes a
valid and binding agreement of each Aura Sound Shareholder,  enforceable against
each  Aura  Sound  Shareholder  in  accordance  with its  terms,  except as such
enforcement  may be limited by  bankruptcy,  insolvency  or other  similar  laws
affecting  the  enforcement  of  creditors'   rights  generally  or  by  general
principles of equity.

      3.3 Restricted Securities.  Each Aura Sound Shareholder  acknowledges that
the Hemcure  Shares will not be  registered  pursuant to the  Securities  Act of
1933, as amended (the "Securities Act") or any applicable state securities laws,
that the Hemcure Shares will be characterized as "restricted  securities"  under
federal securities laws, and that under such laws and applicable regulations the
Hemcure  Shares  cannot be sold or  otherwise  disposed of without  registration
under the Securities Act or an exemption  therefrom.  In this regard,  each Aura
Sound  Shareholder  is familiar with Rule 144  promulgated  under the Securities
Act, as currently in effect,  and  understands  the resale  limitations  imposed
thereby and by the Securities Act.

      3.4  Accredited  Investor.  Each Aura Sound  Shareholder is an "Accredited
Investor" as that term is defined in rule 501 of Regulation D promulgated  under
the  Securities  Act. Each Aura Sound  Shareholder  is able to bear the economic
risk of acquiring the Hemcure  Shares  pursuant to the terms of this  Agreement,
including a complete  loss of such Aura Sound  Shareholder's  investment  in the
Hemcure Shares.

      3.5   Legend.   Each  Aura  Sound   Shareholder   acknowledges   that  the
certificate(s)  representing  such Aura Sound  Shareholder's pro rata portion of
the  Hemcure  Shares  shall  each  conspicuously  set  forth on the face or back
thereof a legend in substantially the following form:

      THESE  SECURITIES  HAVE NOT BEEN  REGISTERED  UNDER THE  SECURITIES ACT OF
      1933,  AS  AMENDED.  THEY MAY NOT BE SOLD,  OFFERED  FOR SALE,  PLEDGED OR
      HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE  REGISTRATION  STATEMENT AS TO
      THE   SECURITIES   UNDER  SAID  ACT  OR  PURSUANT  TO  AN  EXEMPTION  FROM
      REGISTRATION  OR AN OPINION OF COUNSEL  SATISFACTORY  TO THE COMPANY  THAT
      SUCH REGISTRATION IS NOT REQUIRED.

                                       6
<PAGE>

                                    ARTICLE 4
                        REPRESENTATIONS AND WARRANTIES OF
                            HEMCURE, SBC AND LOETHEN

      Hemcure,  SBC and  Loethen  hereby  represent  and  warrant,  jointly  and
severally, to Aura Sound and the Aura Sound Shareholders as follows:

      4.1  Organization.  Hemcure  is  a  corporation  duly  organized,  validly
existing and in good standing under the laws of the state of its  incorporation,
and has the requisite corporate power to carry on its business as now conducted.

      4.2  Capitalization.  Hemcure's  authorized  capital stock consists of (i)
100,000,000  shares of common  stock,  of which  563,695  shares  are issued and
outstanding,  and (ii) 20,000,000  shares of preferred stock,  none of which are
issued  and  outstanding.  At the  Closing,  Hemcure  shall  have no  more  than
17,505,305  issued and outstanding  shares of common stock (including all shares
of common stock sold in the private  placement  described  in Section  7.1(c) of
this Agreement).  All issued and outstanding shares of Hemcure capital stock are
duly  authorized,  validly  issued,  fully  paid,  non-assessable  and  free  of
preemptive  rights.  When issued,  the Hemcure  Shares will be duly  authorized,
validly issued, fully paid,  non-assessable and free of preemptive rights. There
are no outstanding or authorized options, rights,  warrants,  calls, convertible
securities,  rights  to  subscribe,  conversion  rights or other  agreements  or
commitments  to which  Hemcure  is a party or which  are  binding  upon  Hemcure
providing  for the  issuance  by Hemcure or  transfer  by Hemcure of  additional
shares of Hemcure's capital stock and Hemcure has not reserved any shares of its
capital stock for issuance,  nor are there any outstanding  stock option rights,
phantom  equity or similar  rights,  contracts,  arrangements  or commitments to
issue capital stock of Hemcure.  To  Hemcure's,  SBC's and Loethen's  knowledge,
there  are no  voting  trusts or any other  agreements  or  understandings  with
respect to the voting of Hemcure's  capital  stock.  There are no obligations of
Hemcure to repurchase,  redeem or otherwise re-acquire any shares of its capital
stock as of the Closing. Other than (a) the shares of Hemcure common stock to be
registered  pursuant to an anticipated  convertible  loan to Hemcure at or after
the  Closing in the  principal  amount of  $5,500,000  and the shares of Hemcure
common stock to be registered  pursuant to the PPM (as defined in Section 7.1(c)
hereof),  (b) 1,229,476  shares of common stock held or to be held by Next Stage
Investments, LLC, (c) 619,329 shares held or to be held by Galway Holdings, LLC,
and (d) 1,285,714 shares of common stock  underlying  warrants issued to certain
bridge lenders of Aura Sound, Hemcure does not have any outstanding  obligations
to register any of its shares of capital stock with the  Securities and Exchange
Commission.

      4.3 Certain Corporate Matters. Hemcure is duly licensed or qualified to do
business and is in good standing as a foreign  corporation in every jurisdiction
in which the character of Hemcure's  properties or nature of Hemcure's  business
requires it to be so  licensed or  qualified  other than such  jurisdictions  in
which the  failure to be so licensed  or  qualified  does not, or insofar as can
reasonably be foreseen,  in the future will not, have a material  adverse effect
on its financial condition,  results of operations or business. Hemcure has full
corporate  power and  authority  and all  authorizations,  licenses  and permits
necessary  to  carry on the  business  in  which  it is  engaged  or in which it
proposes presently to engage and to own and use the properties owned and used by
it.  Hemcure has delivered to Aura Sound true,  accurate and complete  copies of
its  certificate  or articles of  incorporation  and bylaws,  which  reflect all
restatements  of and  amendments  made  thereto at any time prior to the date of
this  Agreement.  The  records  of  meetings  of the  stockholders  and board of
directors  of Hemcure are complete  and correct in all  material  respects.  The
stock  records and  stockholder  list of Hemcure  that  Hemcure  has  previously
furnished to Aura Sound are  complete  and correct in all material  respects and
accurately reflect the record ownership and the beneficial  ownership of all the
outstanding  shares  of  Hemcure's  capital  stock  and  any  other  outstanding
securities issued by Hemcure. Hemcure is not in default under or in violation of
any provision of its certificate or articles of  incorporation  or bylaws in any
material respect.  Hemcure is not in any material default or in violation of any
restriction,  lien,  encumbrance,  indenture,  contract,  lease, sublease,  loan
agreement,  note or other  obligation  or  liability  by which it is bound or to
which any of its assets is subject.

      4.4 Authority Relative to this Agreement. Each of Hemcure, SBC and Loethen
has the requisite power and authority to enter into this Agreement and carry out
its or his  obligations  hereunder.  The execution,  delivery and performance of
this Agreement by Hemcure and the consummation of the transactions  contemplated
hereby have been duly  authorized  by the board of  directors  of Hemcure and no
other actions on the part of Hemcure are necessary to authorize  this  Agreement
or the  transactions  contemplated  hereby.  This  Agreement  has been  duly and
validly  executed and  delivered by Hemcure,  SBC and Loethen and  constitutes a
valid and  binding  obligation  of  Hemcure,  SBC and  Loethen,  enforceable  in
accordance  with  its  terms,  except  as such  enforcement  may be  limited  by
bankruptcy,  insolvency  or other  similar laws  affecting  the  enforcement  of
creditors' rights generally or by general principles of equity.

                                       7
<PAGE>

      4.5  Consents  and  Approvals;   No  Violations.   Except  for  applicable
requirements of federal  securities laws and state  securities or blue-sky laws,
no filing with, and no permit, authorization,  consent or approval of, any third
party,  public body or authority is necessary for the consummation by Hemcure of
the  transactions  contemplated  by this  Agreement.  Neither the  execution and
delivery of this  Agreement  by Hemcure nor the  consummation  by Hemcure of the
transactions  contemplated  hereby,  nor  compliance  by Hemcure with any of the
provisions  hereof,  will (a)  conflict  with or  result  in any  breach  of any
provisions  of the  charter or bylaws of Hemcure,  (b) result in a violation  or
breach of, or constitute (with or without due notice or lapse of time or both) a
default (or give rise to any right of termination, cancellation or acceleration)
under, any of the terms,  conditions or provisions of any note, bond,  mortgage,
indenture,  license,  contract,  agreement or other  instrument or obligation to
which  Hemcure  (as  hereinafter  defined) is a party or by which they or any of
their  respective  properties  or assets may be bound or (c)  violate any order,
writ, injunction,  decree, statute, rule or regulation applicable to Hemcure, or
any of their respective  properties or assets, except in the case of clauses (b)
and (c) for  violations,  breaches  or defaults  which are not in the  aggregate
material to Hemcure taken as a whole.

      4.6  SEC  Documents.  Hemcure  hereby  makes  reference  to the  following
documents filed with the United States  Securities and Exchange  Commission (the
"SEC"),  as posted on the SEC's website,  www.sec.gov:  (collectively,  the "SEC
Documents"):  (a) Annual  Report on Form 10-KSB for the fiscal  years ended June
30, 2006 and 2004; (b) Form  10-SB12G/A  filed with the SEC on October 17, 2005,
and (c)  Quarterly  Reports on Form 10-QSB for the periods  ended  September 30,
December  31 and March 31,  2005 and 2004;  and (c)  Quarterly  Reports  on Form
10-QSB for the  periods  ended  September  30 and  December  31,  2006;  and any
amendments  thereto.  The SEC  Documents  constitute  all of the  documents  and
reports  that  Hemcure  was  required  to  file  with  the SEC  pursuant  to the
Securities  Exchange Act of 1934 ("Exchange  Act") and the rules and regulations
promulgated  thereunder by the SEC since June 30, 2004.  As of their  respective
dates, the SEC Documents complied in all material respects with the requirements
of the Securities Act and/or the Exchange Act, as the case may require,  and the
rules  and  regulations  promulgated  thereunder  and none of the SEC  Documents
contained an untrue  statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the statements  therein,
in light of the  circumstances  under which they were made, not misleading.  The
financial  statements of Hemcure included in the SEC Documents comply as to form
in all  material  respects  with  applicable  accounting  requirements  and  the
published  rules and  regulations  of the SEC with  respect  thereto,  have been
prepared in accordance  with  generally  accepted  accounting  principles in the
United  States  ("GAAP")  (except,  in the  case  of  unaudited  statements,  as
permitted by the  applicable  form under the Securities Act or the Exchange Act)
applied on a  consistent  basis  during the periods  involved  (except as may be
indicated in the notes  thereto) and fairly  present the  financial  position of
Hemcure as of the dates thereof and its  consolidated  statements of operations,
stockholders' equity and cash flows for the periods then ended (subject,  in the
case of unaudited statements, to normal and recurring year-end audit adjustments
which were and are not  expected to have a material  adverse  effect on Hemcure,
its business,  financial  condition or results of operations).  Except as and to
the extent set forth on the balance  sheet of Hemcure as of December  31,  2006,
including  the notes  thereto,  Hemcure has no  liability or  obligation  of any
nature (whether accrued, absolute,  contingent or otherwise and whether required
to be reflected on a balance sheet or not).

                                       8
<PAGE>

      4.7 Financial Statements.

            (a) Included in the SEC Documents are the audited  balance sheets of
Hemcure  as at June 30,  2006,  2005 and 2004,  and the  related  statements  of
operations,  stockholders' equity and cash flows for the three years then ended,
together  with  the   unqualified   report  thereon   (except  with  respect  to
continuation  as a going  concern) of  Schumacher &  Associates  ("Schumacher"),
independent auditors (collectively, "Hemcure's Audited Financials").

            (b) Included in the SEC Documents are the unaudited balance sheet of
Hemcure as at December  31,  2006,  and the related  statements  of  operations,
stockholders' equity and cash flows for the three months then ended, as reviewed
by Schumacher ("Hemcure's Interim Financials").

            (c) Hemcure's Audited  Financials and Hemcure's  Interim  Financials
(collectively  "Hemcure's Financial  Statements") (i) are in accordance with the
books and records of Hemcure,  (ii) are  correct  and  complete in all  material
respects,  (iii) fairly present the financial position and results of operations
of Hemcure as of the dates  indicated,  and (iv) are prepared in accordance with
GAAP (except that (x) unaudited  financial  statements  may not be in accordance
with GAAP because of the absence of footnotes normally  contained  therein,  and
(y)  interim  (unaudited)  financials  are  subject  to  normal  year-end  audit
adjustments  that in the aggregate  will not have a material  adverse  effect on
Hemcure  , their  respective  businesses,  financial  condition  or  results  of
operations.

      4.8 Events Subsequent to Financial Statements.  Since June 30, 2006, there
has not been:

            (a) Any sale, lease, transfer,  license or assignment of any assets,
tangible or intangible, of Hemcure;

            (b) Any damage, destruction or property loss, whether or not covered
by insurance, affecting adversely the properties or business of Hemcure;

            (c) Any  declaration  or setting aside or payment of any dividend or
distribution  with  respect  to the  shares of  capital  stock of Hemcure or any
redemption, purchase or other acquisition of any such shares;

            (d) Any  subjection  to any lien on any of the  assets,  tangible or
intangible, of Hemcure;

            (e) Any  incurrence  of  indebtedness  or liability or assumption of
obligations by Hemcure;

            (f) Any waiver or  release  by Hemcure of any right of any  material
value;

            (g) Any  compensation  or benefits  paid to officers or directors of
Hemcure;

            (h) Any change made or authorized  in the articles of  incorporation
or bylaws of Hemcure, except for the change to the articles of incorporation and
by-laws made incident to re-domiciling from Minnesota to Nevada;

            (i) Any loan to or other  transaction with any officer,  director or
stockholder of Hemcure giving rise to any claim or right of Hemcure  against any
such person or of such person against Hemcure; or

            (j) Any  material  adverse  change in the  condition  (financial  or
otherwise) of the  respective  properties,  assets,  liabilities  or business of
Hemcure.

                                       9
<PAGE>

      4.9  Liabilities.  Except as otherwise  disclosed  in Hemcure's  Financial
Statements, Hemcure does not have any liability or obligation whatsoever, either
direct or indirect,  matured or  unmatured,  accrued,  absolute,  contingent  or
otherwise.  In addition,  Hemcure,  SBC and Loethen represent that upon Closing,
Hemcure will not have any liability or obligation  whatsoever,  either direct or
indirect, matured or unmatured, accrued, absolute, contingent or otherwise.

      4.10 Tax Matters.

            (a) Hemcure has duly filed all federal, state, local and foreign tax
returns  required to be filed by or with respect to it with the Internal Revenue
Service or other applicable taxing authority,  and no extensions with respect to
such tax returns have been requested or granted;

            (b) Hemcure has paid,  or adequately  reserved  against in Hemcure's
Financial Statements, all material taxes due, or claimed by any taxing authority
to be due, from or with respect to them;

            (c) To the best  knowledge  of  Hemcure,  there has been no material
issue  raised or  material  adjustment  proposed  (and none is  pending)  by the
Internal Revenue Service or any other taxing authority in connection with any of
Hemcure's tax returns;

            (d) No waiver or extension of any statute of  limitations  as to any
material  federal,  state,  local or  foreign  tax  matter  has been given by or
requested from Hemcure; and

            For the  purposes  of this  Section  4.10,  a tax is due  (and  must
therefore either be paid or adequately  reserved against in Hemcure's  Financial
Statements)  only on the  last  date  payment  of such  tax can be made  without
interest  or  penalties,  whether  such  payment is due in respect of  estimated
taxes, withholding taxes, required tax credits or any other tax.

      4.11 Real Property. Hemcure does not own or lease any real property.

      4.12 Books and Records. The books and records of Hemcure delivered to Aura
Sound prior to the Closing fully and fairly  reflect the  transactions  to which
Hemcure is a party or by which its properties are bound.

      4.13 Questionable  Payments.  Neither Hemcure, nor any employee,  agent or
representative  of  Hemcure  has,  directly  or  indirectly,  made  any  bribes,
kickbacks,  illegal payments or illegal  political  contributions  using Company
funds or made any payments from Hemcure's  funds to  governmental  officials for
improper purposes or made any illegal payments from Hemcure's funds to obtain or
retain business.

      4.14  Intellectual  Property.  Hemcure does not own or use any trademarks,
trade names, service marks, patents, copyrights or any applications with respect
thereto.  Hemcure,  SBC and Loethen  have no  knowledge  of any claim  that,  or
inquiry as to whether,  any product,  activity or operation of Hemcure infringes
upon or  involves,  or has  resulted  in the  infringement  of, any  trademarks,
trade-names,  service marks, patents,  copyrights or other proprietary rights of
any other person, corporation or other entity; and no such proceedings have been
instituted, are pending or are threatened against Hemcure.

      4.15 Insurance. Hemcure does not have any insurance policies in effect.

      4.16  Contracts.  Except as set forth on Schedule  4.16,  Hemcure does not
have any material contracts,  leases,  arrangements or commitments (whether oral
or written).  Hemcure is not a party to or bound by or affected by any contract,
lease,  arrangement or commitment (whether oral or written) relating to: (a) the
employment of any person; (b) collective  bargaining with, or any representation
of any  employees by, any labor union or  association;  (c) the  acquisition  of
services,  supplies,  equipment or other personal property;  (d) the purchase or
sale of real property;  (e) distribution,  agency or construction;  (f) lease of
real or personal  property as lessor or lessee or  sublessor or  sublessee;  (g)
lending or advancing of funds; (h) borrowing of funds or receipt of credit;  (i)
incurring any obligation or liability; or (j) the sale of personal property.

                                       10
<PAGE>

      4.17  Litigation.  Hemcure is not subject to any  judgment or order of any
court or quasijudicial or administrative agency of any jurisdiction, domestic or
foreign,   nor  is  there  any  charge,   complaint,   lawsuit  or  governmental
investigation pending against Hemcure. Hemcure is not a plaintiff in any action,
domestic or foreign, judicial or administrative.  There are no existing actions,
suits, proceedings against or investigations of Hemcure, and Hemcure knows of no
basis for such  actions,  suits,  proceedings  or  investigations.  There are no
unsatisfied  judgments,  orders, decrees or stipulations affecting Hemcure or to
which Hemcure is a party.

      4.18 Employees.  Hemcure does not have any employees. Hemcure does not owe
any compensation of any kind, deferred or otherwise,  to any current or previous
employees. Hemcure does not have a written or oral employment agreement with any
officer  or  director  of  Hemcure.  Hemcure  is not a party  to or bound by any
collective bargaining agreement. There are no loans or other obligations payable
or owing by  Hemcure  to any  stockholder,  officer,  director  or  employee  of
Hemcure,  nor are  there  any  loans  or debts  payable  or owing by any of such
persons to Hemcure or any guarantees by Hemcure of any loan or obligation of any
nature to which any such person is a party.

      4.19 Employee Benefit Plans.  Hemcure does not have any (a)  non-qualified
deferred or incentive  compensation  or retirement  plans or  arrangements,  (b)
qualified  retirement  plans or arrangements,  (c) other employee  compensation,
severance or termination pay or welfare benefit plans,  programs or arrangements
or (d) any related  trusts,  insurance  contracts or other funding  arrangements
maintained, established or contributed to by Hemcure.

      4.20  Legal  Compliance.  To the best  knowledge  of  Hemcure,  after  due
investigation,  no claim has been filed against Hemcure  alleging a violation of
any  applicable  laws or  regulations  of  foreign,  federal,  state  and  local
governments and all agencies thereof. Hemcure holds all of the material permits,
licenses,  certificates or other  authorizations of foreign,  federal,  state or
local governmental agencies required for its business as presently conducted.

      4.21 Subsidiaries and Investments.  Hemcure does not own any capital stock
or have any interest of any kind whatsoever in any corporation,  partnership, or
other form of business organization.

      4.22 Broker's Fees.  Neither  Hemcure,  nor anyone on its behalf,  has any
liability to any broker,  finder,  investment  banker or agent, or has agreed to
pay any  brokerage  fees,  finder's  fees or  commissions,  or to reimburse  any
expenses of any broker,  finder,  investment  banker or agent in connection with
this Agreement.

      4.23 Internal Accounting Controls.  Hemcure maintains a system of internal
accounting  controls  sufficient  to  provide  reasonable   assurance  that  (i)
transactions  are executed in accordance with  management's  general or specific
authorizations,   (ii)   transactions   are  recorded  as  necessary  to  permit
preparation  of financial  statements  in  conformity  with GAAP and to maintain
asset  accountability,  (iii) access to assets is permitted  only in  accordance
with  management's  general or  specific  authorization,  and (iv) the  recorded
accountability  for assets is compared  with the existing  assets at  reasonable
intervals  and  appropriate  action is taken with  respect  to any  differences.
Hemcure  has  established  disclosure  controls  and  procedures  (as defined in
Exchange  Act Rules  13a-15(e)  and  15d-15(e))  for Hemcure and  designed  such
disclosure controls and procedures to ensure that material  information relating
to Hemcure is made  known to the  certifying  officers  by others  within  those
entities,  particularly  during the  period in which  Hemcure's  Form  10-KSB or
10-QSB,  as the case may be, is being prepared.  Hemcure's  certifying  officers
have evaluated the effectiveness of Hemcure's  controls and procedures as of end
of the filing period prior to the filing date of the Form 10-QSB for the quarter
ended December 31, 2006 (such date, the "Evaluation Date"). Hemcure presented in
its most  recently  filed  Form  10-KSB or Form  10-QSB the  conclusions  of the
certifying  officers  about the  effectiveness  of the  disclosure  controls and
procedures  based on their  evaluations  as of the  Evaluation  Date.  Since the
Evaluation  Date, there have been no significant  changes in Hemcure's  internal
controls  (as such term is defined in Item  307(b) of  Regulation  S-K under the
Exchange  Act) or, to the  Company's  knowledge,  in other  factors  that  could
significantly affect the Company's internal controls.

                                       11
<PAGE>

      4.24  Listing and  Maintenance  Requirements.  Hemcure's  common  stock is
currently  quoted on the OTC Bulletin  Board.  Hemcure has not, since October 1,
2005, received any notice from the OTC Bulletin Board or the NASD or any trading
market on which  Hemcure's  common  stock is or has been listed or quoted to the
effect  that  Hemcure  is  not  in  compliance  with  the  quoting,  listing  or
maintenance requirements of the OTC Bulletin Board or such other trading market.
Hemcure is, and has no reason to believe  that it will not,  in the  foreseeable
future  continue  to be,  in  compliance  with all  such  quoting,  listing  and
maintenance requirements.

      4.25  Application  of  Takeover  Protections.  Hemcure  and its  board  of
directors  have  taken  all  necessary  action,  if  any,  in  order  to  render
inapplicable any control share acquisition,  business  combination,  poison pill
(including  any  distribution   under  a  rights  agreement)  or  other  similar
anti-takeover provision under Hemcure's certificate or articles of incorporation
(or similar charter documents) or the laws of its state of incorporation that is
or could become  applicable  to Aura Sound or the Aura Sound  Shareholders  as a
result of the  Exchange or the  exercise of any rights by Aura Sound or the Aura
Sound Shareholders pursuant to this Agreement.

      4.26 No SEC or NASD  Inquiries.  Neither  Hemcure  nor any of its  past or
present officers or directors is, or has ever been, the subject of any formal or
informal inquiry or investigation by the SEC or NASD.

      4.27 Disclosure. The representations and warranties and statements of fact
made by Hemcure in this  Agreement  are, as  applicable,  accurate,  correct and
complete and do not contain any untrue  statement of a material  fact or omit to
state  any  material  fact  necessary  in  order  to  make  the  statements  and
information contained herein not false or misleading.

                                    ARTICLE 5
                                 INDEMNIFICATION

      5.1  SBC/Loethen  Indemnification.  For a  period  of one year  after  the
Closing,  SBC and Loethen each agree,  jointly and severally,  to indemnify Aura
Sound,  the  Aura  Sound  Shareholders  and  each of the  officers,  agents  and
directors  of Aura  Sound or the  Aura  Sound  Shareholders  against  any  loss,
liability,  claim, damage or expense (including, but not limited to, any and all
expenses whatsoever reasonably incurred in investigating, preparing or defending
against any litigation,  commenced or threatened, or any claim whatsoever) (each
an "Indemnified Party") to which it or they may become subject arising out of or
based on either (i) any breach of or  inaccuracy  in any of the  representations
and  warranties  or covenants or conditions  made by Hemcure,  SBC or Loethen in
this  Agreement;  (ii) any and all  liabilities  arising out of or in connection
with any of the assets,  business or operations of Hemcure prior to the Closing,
or  (iii)  any  breach  of or  inaccuracy  in  any of  the  representations  and
warranties or covenants or conditions made by Hemcure in the RENN Loan Agreement
or the  Subscription  Agreement  attached  as an exhibit to the PPM, in any case
only as such  representations,  warranties,  covenants  or  conditions  apply to
Hemcure prior to the Closing (collectively, the "Loethen Indemnification").

                                       12
<PAGE>

      5.2 Indemnification  Procedures. If any action shall be brought against an
Indemnified  Party in respect of which  indemnity may be sought pursuant to this
Agreement,  such  Indemnified  Party shall  promptly  notify  Loethen and SBC in
writing,  and  Loethen  and SBC shall each have the right to assume the  defense
thereof with counsel of his or its own  choosing.  Any  Indemnified  Party shall
have the right to employ separate  counsel in any such action and participate in
the defense  thereof,  but the fees and expenses of such counsel shall be at the
expense  of such  Indemnified  Party  except to the extent  that the  employment
thereof has been specifically  authorized by Loethen or SBC in writing,  SBC and
Loethen have failed after a reasonable period of time to assume such defense and
to employ counsel or in such action there is, in the reasonable  opinion of such
separate counsel, a material conflict on any material issue between the position
of SBC or Loethen and the position of such  Indemnified  Party.  Neither SBC nor
Loethen  will be liable to any  Indemnified  Party under this  Article 5 for any
settlement  by an  Indemnified  Party  effected  without SBC or Loethen's  prior
written consent, which shall not be unreasonably withheld or delayed.

                                    ARTICLE 6
                     COVENANTS AND AGREEMENTS OF THE PARTIES
                           EFFECTIVE PRIOR TO CLOSING

      6.1 Corporate Examinations and Investigations.  Prior to the Closing, each
party shall be entitled, through its employees and representatives, to make such
investigations and examinations of the books, records and financial condition of
Aura Sound and Hemcure as each party may  request.  In order that each party may
have the full  opportunity  to do so, Aura Sound and Hemcure  shall furnish each
party and its  representatives  during  such  period  with all such  information
concerning  the  affairs  of  Aura  Sound  or  Hemcure  as  each  party  or  its
representatives may reasonably request and cause Aura Sound or Hemcure and their
respective officers, employees,  consultants,  agents, accountants and attorneys
to cooperate  fully with each party's  representatives  in connection  with such
review  and  examination  and to make full  disclosure  of all  information  and
documents   requested   by  each   party  or  its   representatives.   Any  such
investigations and examinations shall be conducted at reasonable times and under
reasonable  circumstances,  it being  agreed  that any  examination  of original
documents will be at each party's  premises,  with copies thereof to be provided
to each party or its representatives upon request.

      6.2  Cooperation;  Consents.  Prior  to  the  Closing,  each  party  shall
cooperate  with the other  parties  to the end that the  parties  shall (i) in a
timely manner make all necessary  filings with, and conduct  negotiations  with,
all  authorities  and other  persons the  consent or  approval of which,  or the
license or permit from which is required  for the  consummation  of the Exchange
and (ii)  provide to each other  party such  information  as the other party may
reasonably  request in order to enable it to prepare such filings and to conduct
such negotiations.

      6.3 Conduct of Business.  Subject to the provisions hereof,  from the date
hereof through the Closing,  each party hereto shall (i) conduct its business in
the  ordinary  course  and in such a  manner  so that  the  representations  and
warranties  contained  herein  shall  continue  to be true  and  correct  in all
material respects as of the Closing as if made at and as of the Closing and (ii)
not enter into any material  transactions  or incur any material  liability  not
required or  specifically  contemplated  hereby,  without  first  obtaining  the
written  consent of Aura Sound and the Aura Sound  Shareholders  on the one hand
and  Hemcure,  SBC and  Loethen on the other  hand.  Without  the prior  written
consent of Aura Sound,  the Aura Sound  Shareholders,  Hemcure,  SBC or Loethen,
except as required or  specifically  contemplated  hereby,  each party shall not
undertake or fail to undertake any action if such action or failure would render
any of said warranties and representations  untrue in any material respect as of
the Closing.

                                       13
<PAGE>

      6.4  Litigation.  From the date  hereof  through the  Closing,  each party
hereto shall  promptly  notify the  representative  of the other  parties of any
lawsuits,  claims, proceedings or investigations which after the date hereof are
threatened  or  commenced  against  such party or any of its  affiliates  or any
officer, director, employee,  consultant, agent or shareholder thereof, in their
capacities as such, which, if decided adversely, could reasonably be expected to
have a material  adverse  effect upon the condition  (financial  or  otherwise),
assets, liabilities,  business,  operations or prospects of such party or any of
its subsidiaries.

      6.5 Notice of Default.  From the date hereof  through  the  Closing,  each
party  hereto  shall  give to the  representative  of the other  parties  prompt
written  notice of the  occurrence  or  existence  of any  event,  condition  or
circumstance  occurring  which would  constitute  a violation  or breach of this
Agreement by such party or which would render inaccurate in any material respect
any of such party's representations or warranties herein.

                                    ARTICLE 7
                              CONDITIONS TO CLOSING

      7.1   Conditions  to   Obligations  of  Aura  Sound  and  the  Aura  Sound
Shareholders.  The  obligations  of Aura Sound and the Aura  Sound  Shareholders
under this Agreement shall be subject to each of the following conditions:

            (a) Closing Deliveries. At the Closing, Hemcure shall have delivered
or caused to be delivered to Aura Sound the following:

                  (i)  resolutions  duly  adopted by the board of  directors  of
            Hemcure  authorizing  and approving the Exchange and the  execution,
            delivery and performance of this Agreement;

                  (ii) a  certificate  of good  standing  for  Hemcure  from its
            jurisdiction  of  incorporation,  dated not  earlier  than five days
            prior to the Closing Date;

                  (iii)  written  resignations  of all officers and directors of
            Hemcure  in  office  immediately  prior to the  Closing,  and  board
            resolutions electing the following individuals to the positions with
            Hemcure listed opposite their names below:

                  Arthur Liu            Chairman of the Board, Chief Executive
                                        Officer and Chief Financial Officer
                  Donald North          Vice President Engineering
                  Amy Liu               Director
                  Celia Cheng           Secretary, Director

                  (iv) this Agreement duly executed by Hemcure, SBC and Loethen;

                  (v) all  corporate  records,  agreements,  seals and any other
            information  reasonably  requested by Aura  Sound's  representatives
            with respect to Hemcure; and

                  (vi) such  other  documents  as Aura  Sound or the Aura  Sound
            Shareholders   may  reasonably   request  in  connection   with  the
            transactions contemplated hereby.

            (b)  Representations  and Warranties to be True. The representations
and warranties of Hemcure, SBC and Loethen herein contained shall be true in all
material  respects  at the  Closing  with the same effect as though made at such
time. Hemcure, SBC and Loethen shall have performed in all material respects all
obligations  and  complied  in all  material  respects  with all  covenants  and
conditions  required by this  Agreement to be performed or complied with by them
at or prior to the Closing.

                                       14
<PAGE>

            (c) Private  Placement.  On or before the Closing Date,  Hemcure and
AuraSound shall have in an escrow account for their  collective  benefit no less
than $6,000,000 in gross proceeds pursuant to the Confidential Private Placement
Memorandum,  dated  February 16, 2007, in connection  with the reverse merger of
Hemcure and Aura Sound (the "PPM"), and such funds shall be released from escrow
at the Closing.

            (d) SEC Filings. At the Closing,  Hemcure will be current in all SEC
filings required by it to be filed.

            (e) OTCBB  Trading.  Hemcure's  common  stock  shall be  quoted  and
eligible for trading on the OTC Bulletin Board.

            (f)  Warrants.  At the Closing,  Hemcure  shall issue the  following
warrants:

                  (i) GP Group,  LLC, an affiliate of the placement  agent named
in the PPM,  will  receive a five year  warrant to  purchase  251,429  shares of
common stock at an exercise price of $1.40/share.

                  (ii)  Mapleridge  Investment  Services,  a  bridge  lender  of
AuraSound,  will  receive a  five-year  warrant to  purchase  428,571  shares of
Hemcure common stock at an exercise price of $1.75 per share.

                  (iii) Westrec Properties, Inc. and Affiliated Companies 401(k)
Plan, a bridge lender of AuraSound, will receive a five year warrant to purchase
428,571 shares of Hemcure common stock at an exercise price of $1.75/share.

                  (iv) Apex Investment Fund, Ltd., a bridge lender of AuraSound,
will receive a five year warrant to purchase  428,571  shares of common stock at
an exercise price of $1.75/share.

                  All of the  foregoing  warrants  will be  issued  in form  and
substance  reasonably  acceptable to AuraSound and as required by the applicable
transaction documents requiring the issuance of such warrants.

      7.2 Conditions to Obligations of Hemcure, SBC and Loethen. The obligations
of Hemcure, SBC and Loethen under this Agreement shall be subject to each of the
following conditions:

            (a) Closing Deliveries.  On the Closing Date, Aura Sound or the Aura
Sound Shareholders shall have delivered to Hemcure the following:

                  (i)  certificates  representing  the Aura Sound  Shares,  duly
            endorsed in blank or each accompanied by a stock power effecting the
            transfer thereof to Hemcure;

                  (ii) this  Agreement  duly executed by Aura Sound and the Aura
            Sound Shareholders;

                  (iii) such other  documents as Hemcure may reasonably  request
            in connection with the transactions contemplated hereby.

                                       15
<PAGE>

            (b)  Representations  and Warranties to be True. The representations
and warranties of Aura Sound and the Aura Sound  Shareholders  herein  contained
shall be true in all  material  respects at the Closing  with the same effect as
though made at such time. Aura Sound and the Aura Sound  Shareholders shall have
performed in all material  respects all obligations and complied in all material
respects  with all  covenants and  conditions  required by this  Agreement to be
performed or complied with by them at or prior to the Closing.

                                    ARTICLE 8
                                   TERMINATION

      8.1 Events of  Termination.  This  Agreement  may, by notice  given in the
manner  hereinafter  provided,  be terminated and abandoned at any time prior to
completion of the Closing, as follows:

            (a) by Aura Sound if (1) there has been a material Breach by Hemcure
and, in the case of a covenant or agreement  Breach,  such Breach shall not have
been cured  within ten (10) days after  receipt by Hemcure of notice  specifying
particularly  such  Breach,  (2) if Aura Sound  identifies  hereafter  any fact,
circumstance  or event that could be  reasonably  determined  to have a material
adverse effect on Hemcure and such fact,  circumstance  or event is not cured by
Hemcure  within  ten (10) days after  receipt  by  Hemcure of notice  specifying
particularly such fact, event or circumstance,  or (3) if the closing conditions
set forth in Article 7 have not been  satisfied  by the close of business on May
31, 2007;

            (b) by Hemcure (1) if there has been a material Breach by Aura Sound
and, in the case of a covenant or agreement  Breach,  such Breach shall not have
been cured within ten (10) days after receipt by Aura Sound of notice specifying
particularly  such  Breach,  or (2) if Hemcure  identifies  hereafter  any fact,
circumstance  or event that could be  reasonably  determined  to have a material
adverse effect on Aura Sound,  or Hemcure  following the Merger,  and such fact,
circumstance  or event is not cured by Aura  Sound  within  ten (10) days  after
receipt  by Aura Sound of notice  specifying  particularly  such fact,  event or
circumstance,  or (3) if the closing  conditions set forth in Article 7 have not
been satisfied by the close of business on May 31, 2007; or

            (c) at any  time by  mutual  written  agreement  of Aura  Sound  and
Hemcure.

            This  Agreement  may  not  be  terminated  after  completion  of the
Closing, except by mutual agreement of Aura Sound and Hemcure.

            For the  purposes  of this  Article 8, there shall be deemed to be a
"Breach" of a representation, warranty, covenant, obligation, or other provision
if there is or has been (a) any inaccuracy (subject to applicable  knowledge and
materiality qualifiers, if any) in, or breach of, or any failure to comply with,
or  perform,  such  representation,  warranty,  covenant,  obligation,  or other
provision,  or (b) any  claim  (by any  person)  or other  circumstance  that is
inconsistent with such representation,  warranty, covenant, obligation, or other
provision;  and  the  term  "Breach"  shall  be  deemed  to  refer  to any  such
inaccuracy, breach, failure, claim, or circumstance.

                                    ARTICLE 9
                               GENERAL PROVISIONS

      9.1 Notices.  All notices and other  communications  hereunder shall be in
writing  and shall be deemed to have been duly  given if  delivered  personally,
sent by overnight  courier or mailed by  registered  or certified  mail (postage
prepaid  and  return  receipt  requested)  to the  party  to whom the same is so
delivered,  sent or mailed at the  addresses  set  forth on the  signature  page
hereof  (or at such  other  address  for a party as shall be  specified  by like
notice).

                                       16
<PAGE>

      9.2  Interpretation.  The  headings  contained in this  Agreement  are for
reference  purposes  only  and  shall  not  affect  in any  way the  meaning  or
interpretation  of this Agreement.  References to Sections and Articles refer to
sections and articles of this Agreement unless otherwise stated.

      9.3 Severability.  If any term, provision, covenant or restriction of this
Agreement is held by a court of competent  jurisdiction  to be invalid,  void or
unenforceable,   the   remainder  of  the  terms,   provisions,   covenants  and
restrictions  of this Agreement  shall remain in full force and effect and shall
in no way be affected,  impaired or invalidated  and the parties shall negotiate
in good faith to modify this  Agreement  to preserve  each  party's  anticipated
benefits under this Agreement.

      9.4 Miscellaneous.  This Agreement (together with all schedules, documents
and instruments  referred to herein):  (a) constitutes the entire  agreement and
supersedes all other prior agreements and  undertakings,  both written and oral,
among the parties  with  respect to the  subject  matter  hereof;  (b) except as
expressly set forth herein,  is not intended to confer upon any other person any
rights or remedies  hereunder  and (c) shall not be assigned by operation of law
or otherwise, except as may be mutually agreed upon by the parties hereto.

      9.5 Separate Counsel. Each party hereby expressly acknowledges that it has
been advised to seek its own separate  legal  counsel for advice with respect to
this  Agreement,  and that no counsel to any party hereto has acted or is acting
as counsel to any other party hereto in connection with this Agreement.

      9.6  Governing  Law;  Venue.  This  Agreement  shall be  governed  by, and
construed and enforced in accordance  with, the laws of the State of California.
Any and all actions  brought under this Agreement  shall be brought in the state
or federal  courts of the  United  States  sitting  in the City of Los  Angeles,
California  and each party hereby waives any right to object to the  convenience
of such venue.

      9.7 Counterparts and Facsimile Signatures.  This Agreement may be executed
in two or more counterparts, which together shall constitute a single agreement.
This Agreement and any documents  relating to it may be executed and transmitted
to any other  party by  facsimile,  which  facsimile  shall be deemed to be, and
utilized in all respects as, an original, wet-inked document.

      9.8  Amendment.  This Agreement may be amended,  modified or  supplemented
only by an instrument in writing executed by Hemcure, Aura Sound and the holders
of at least 75% of the Aura Sound Shares.

      9.9 Parties In Interest: No Third Party Beneficiaries. Except as otherwise
provided  herein,  the terms and conditions of this Agreement shall inure to the
benefit of and be binding  upon the  respective  heirs,  legal  representatives,
successors and assigns of the parties hereto. This Agreement shall not be deemed
to confer upon any person not a party hereto any rights or remedies hereunder.

      9.10  Waiver.  No waiver by any party of any  default or breach by another
party of any representation,  warranty,  covenant or condition contained in this
Agreement shall be deemed to be a waiver of any subsequent  default or breach by
such  party of the  same or any  other  representation,  warranty,  covenant  or
condition. No act, delay, omission or course of dealing on the part of any party
in exercising  any right,  power or remedy under this  Agreement or at law or in
equity  shall  operate as a waiver  thereof or otherwise  prejudice  any of such
party's rights, powers and remedies. All remedies,  whether at law or in equity,
shall be cumulative  and the election of any one or more shall not  constitute a
waiver of the right to pursue other available remedies.

                                       17
<PAGE>

      9.11  Expenses.  At or prior to the Closing,  the parties hereto shall pay
all of their own  expenses  relating to the  transactions  contemplated  by this
Agreement,  including,  without  limitation,  the  fees  and  expenses  of their
respective counsel and financial advisers.

      9.12   Recitals   Incorporated.   The  recitals  of  this   Agreement  are
incorporated herein and made a part hereof.

                               [SIGNATURES FOLLOW]

                                       18
<PAGE>

      IN WITNESS  WHEREOF,  the parties have executed  this  Agreement as of the
date first written above.

                                        Aura Sound, Inc.,
                                        a California corporation

                                        By: ___________________________
                                        Name: Arthur Liu
                                        Title: Chief Executive Officer

Address:

11839 East Smith Avenue
Santa Fe Springs, CA 90670

With a copy to (which shall not constitute notice):

Richardson & Patel, LLP
The Chrysler Building
405 Lexington Avenue
26th Floor
New York, NY 10174
Attention: Kevin Friedmann, Esq.

                  [SIGNATURE PAGES OF AURA SOUND SHAREHOLDERS,
                        HEMCURE, SBC AND LOETHEN FOLLOW]

                                       19
<PAGE>

                   [SIGNATURE PAGE OF AURA SOUND SHAREHOLDERS]

Name                       Signature                     Address
--------------------------------------------------------------------------------

Arthur Liu
--------------------------------------------------------------------------------

                           By:
Haztlacha Investment       Its:
--------------------------------------------------------------------------------

Warren Braslow
--------------------------------------------------------------------------------

Maurice Zeitlin
--------------------------------------------------------------------------------

Gimilis Chesed Keren
Chava B'Nai Levi           By:
Association                Its:
--------------------------------------------------------------------------------

                        [INSERT AURA SOUND SHAREHOLDERS:]

                                       20
<PAGE>

                  [SIGNATURE PAGE OF HEMCURE, SBC AND LOETHEN]

                                        Hemcure, Inc., a Nevada corporation

                                        By:  __________________________
                                        Name:  Bartly J. Loethen
                                        Title: Chief Executive Officer

                                        Synergy Business Consulting, LLC

                                        By:  __________________________
                                               Bartley J. Loethen
                                        Its:  Managing Member

                                        _______________________________
                                        Bartly J. Loethen, an individual

                                       21
<PAGE>

                                   SCHEDULE I

<TABLE>
<CAPTION>
                                              Column I                           Column II
Name                                Number of Shares of Aura Sound     Number of Shares of Hemcure
--------------------------------------------------------------------------------------------------
<S>                                          <C>                                <C>
Arthur Liu                                   10,647,071                         10,647,071
--------------------------------------------------------------------------------------------------
Haztlacha Investment                            377,082                            377,082
--------------------------------------------------------------------------------------------------
Warren Braslow                                  219,883                            219,883
--------------------------------------------------------------------------------------------------
Maurice Zeitlin                                 147,475                            147,475
--------------------------------------------------------------------------------------------------
Gimilis Chesed Keren Chava
B'Nai Levi Association                          113,794                            113,794
--------------------------------------------------------------------------------------------------

--------------------------------------------------------------------------------------------------
                         Total               11,505,305                         11,505,305
--------------------------------------------------------------------------------------------------
</TABLE>

                                       22
<PAGE>

                                  SCHEDULE 4.16

Hemcure,  Inc.  engages  services  from the following  providers:  ComputerShare
(transfer agent); Synergy Law Group, LLC (legal);  Vintage Filings (EDGAR filing
services); and Schumacher & Associates, Inc. (accounting services).

                                       23
<PAGE>

                                    EXHIBIT A

                      Form of Articles of Exchange (Nevada)

                                       24

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00117-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00117-of-00352.parquet"}]]